Weizmann Institute of Science

Nobel Prize, Israel Prize laureate, Ada Yonath, dies aged 87

Professor Ada Yonath won the Nobel Prize in Chemistry in 2009 and the Israel Prize in Chemistry in 2002. She was born in Jerusalem and worked at Weizmann Institute of Science, Rehovot.

Israeli Nobel laureate Ada Yonath pictured in 2016.
ISRAEL MAKOV at the ‘Viewpoints’ book launch.

Israel Makov opens a window into six decades of collecting and championing Israeli art

ASAPH AHARONI

Climate change is stripping nutrients from food, global study with Israeli expert warns

LIVE IMAGING of ear tissue shows that blocking the Notch pathway disrupts stable cell structure, forcing green supporting cells to transform into red hair cells.

Breakthrough Israeli study finds potential path to reversing hearing loss


Israeli, Czech scientists recreate COVID-19’s evolutionary journey in a test tube

Scientists and doctors keep closely monitoring viruses that could jump from animals to humans, such as emerging strains of avian flu and bat coronaviruses.

AVIV SHOSHANY (left) and Prof. Gideon Schreiber.

Q-Factor emerges as Israel’s latest quantum computing developer with $24 million seed investment

The investment, which included NFX, TPY Capital, and Intel Capital, aims to commercialize a quantum computing project developed by professors from the Technion and Weizmann Institute.

Q-Factor is led by professors from the Technion, the Weizmann Institute, and experts in the world of deep-tech startups.

Weizmann Institue, NASA discover Jupiter is smaller and flatter than previously believed

“This research helps us understand how planets form and evolve… by studying what’s happening inside Jupiter, we get closer to understanding how planets like ours came to be.”

A VIEW of Jupiter's moon Europa created from images taken by NASA's Galileo spacecraft in the late 1990's, according to NASA, obtained by Reuters May 14, 2018.

Understanding lifespan: Genes may unlock path to healthier aging, scientists say - study

Research by Weizmann scientists finds genetics may explain 50% of human lifespan, over twice previous estimates, opening doors to therapies targeting aging itself.

Biotech Breakthrough Lets Doctors Track Immunity in Minutes

Triennial report: Israeli science at the precipice

The Israel Academy of Sciences and Humanities warns of the danger of losing independence and being left out of research collaborations.

A STATUE of Albert Einstein in the garden of the Israel Academy of Sciences and Humanities.

TAU discovers breakthough mechanism for treating deadliest type of skin cancer

A major achievement with far-reaching implications for treating deadly skin cancer has been discovered by Tel Aviv University scientists and colleagues.

THE RESEARCH TEAM (from bottom left, counterclockwise): Stav Melamed, Prof. Carmit Levy, Paulee Manich, and Yuval Sade.

Rapid pandemic response: Israeli bio-chip instantly maps antibody defense

The technology is designed to rapidly map antibody responses and may become a key tool in preparing for future pandemics.

Biotech Breakthrough Lets Doctors Track Immunity in Minutes

How sex hormones make our internal clocks 'tick'

Weizmann Institute molecular geneticist discovers what makes humans ‘tick’ and causes disruptions during menstruation, pregnancy, and menopause.

THE SUN sets behind the Houses of Parliament in London. It’s known that circadian clocks are affected not only by external signals such as sunlight but also by signals carried through the bloodstream.

'When I grow up, I want to be like you': remembering Morris Kahn's most productive years - opinion

Founder of the Genesis Prize Stan Polovets on why your seventies and eighties – and even nineties – can be your most impactful years.

FOUNDER OF the Genesis Prize Stan Polovets, New England Patriots owner Robert Kraft, and Morris Kahn in 2019.

Breakthrough Tel Aviv University study uncovers how skin cancer outsmarts immune system

The study shows that melanoma cells release tiny bubble-like structures called extracellular vesicles, or EVs, which can paralyze the immune cells that normally attack tumors.

A 3D immunofluorescent image of melanoma cells (magenta) infected with bacteria (turquoise); cell nuclei are blue